Lexaria Bioscience Corp. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Lexaria Bioscience Corp. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q4 2024.
  • Lexaria Bioscience Corp. Net Income (Loss) Attributable to Parent for the quarter ending November 30, 2024 was -$2.7M, a 129% decline year-over-year.
  • Lexaria Bioscience Corp. Net Income (Loss) Attributable to Parent for the twelve months ending November 30, 2024 was -$7.32M, a 20.2% decline year-over-year.
  • Lexaria Bioscience Corp. annual Net Income (Loss) Attributable to Parent for 2024 was -$5.8M, a 13% increase from 2023.
  • Lexaria Bioscience Corp. annual Net Income (Loss) Attributable to Parent for 2023 was -$6.66M, a 8.32% increase from 2022.
  • Lexaria Bioscience Corp. annual Net Income (Loss) Attributable to Parent for 2022 was -$7.27M, a 80.5% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$7.32M -$2.7M -$1.52M -129% Sep 1, 2024 Nov 30, 2024 10-Q 2025-01-10
Q3 2024 -$5.8M -$2.18M -$945K -76.3% Jun 1, 2024 Aug 31, 2024 10-K 2024-11-26
Q2 2024 -$4.85M -$1.78M +$590K +24.9% Mar 1, 2024 May 31, 2024 10-Q 2024-07-12
Q1 2024 -$5.44M -$650K +$649K +50% Dec 1, 2023 Feb 29, 2024 10-Q 2024-07-12
Q4 2023 -$6.09M -$1.18M +$577K +32.8% Sep 1, 2023 Nov 30, 2023 10-Q 2025-01-10
Q3 2023 -$6.66M -$1.24M +$228K +15.5% Jun 1, 2023 Aug 31, 2023 10-K 2024-11-26
Q2 2023 -$6.89M -$2.37M +$11.4K +0.48% Mar 1, 2023 May 31, 2023 10-Q 2024-07-12
Q1 2023 -$6.9M -$1.3M +$128K +8.95% Dec 1, 2022 Feb 28, 2023 10-Q 2024-07-12
Q4 2022 -$7.03M -$1.76M +$237K +11.9% Sep 1, 2022 Nov 30, 2022 10-Q 2024-07-12
Q3 2022 -$7.27M -$1.47M -$289K -24.6% Jun 1, 2022 Aug 31, 2022 10-K 2023-11-20
Q2 2022 -$6.98M -$2.38M +$184K +7.16% Mar 1, 2022 May 31, 2022 10-Q 2023-07-14
Q1 2022 -$7.16M -$1.43M -$1.82M -463% Dec 1, 2021 Feb 28, 2022 10-Q 2023-07-14
Q4 2021 -$5.34M -$1.99M -$1.28M -181% Sep 1, 2021 Nov 30, 2021 10-Q 2023-07-14
Q3 2021 -$4.06M -$1.18M -$406K -52.7% Jun 1, 2021 Aug 31, 2021 10-Q 2022-01-14
Q2 2021 -$3.66M -$2.57M -$1.18M -84.6% Mar 1, 2021 May 31, 2021 10-Q 2022-07-14
Q1 2021 -$2.48M $393K +$1.39M Dec 1, 2020 Feb 28, 2021 10-Q 2022-04-11
Q4 2020 -$3.87M -$710K +$215K +23.2% Sep 1, 2020 Nov 30, 2020 10-Q 2022-01-14
Q3 2020 -$4.08M -$772K Jun 1, 2020 Aug 31, 2020 10-K 2021-11-29
Q2 2020 -$1.39M Mar 1, 2020 May 31, 2020 10-Q 2021-07-15
Q1 2020 -$997K Dec 1, 2019 Feb 29, 2020 10-Q 2021-04-14
Q4 2019 -$925K -$223K -31.8% Sep 1, 2019 Nov 30, 2019 10-Q 2021-01-14
Q4 2018 -$701K -$123K -21.2% Sep 1, 2018 Nov 30, 2018 10-Q 2020-01-09
Q4 2017 -$579K Sep 1, 2017 Nov 30, 2017 10-Q 2019-01-11
Q4 2015 -$412K -$13.7K -3.43% Sep 1, 2015 Nov 30, 2015 10-Q 2016-01-08
Q4 2014 -$398K Sep 1, 2014 Nov 30, 2014 10-Q 2016-01-08
Q1 2012 -$603K -$232K -$76.4K -49% Feb 1, 2012 Apr 30, 2012 10-Q 2012-06-07
Q4 2011 -$527K -$119K +$11.3K +8.65% Nov 1, 2011 Jan 31, 2012 10-Q 2012-03-13
Q3 2011 -$538K $687 Aug 1, 2011 Oct 31, 2011 10-K 2012-01-30
Q2 2011 -$253K -$224K -760% May 1, 2011 Jul 31, 2011 10-Q 2011-09-14
Q1 2011 -$156K Feb 1, 2011 Apr 30, 2011 10-Q 2012-06-07
Q4 2010 -$130K Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-13
Q2 2010 -$29.4K May 1, 2010 Jul 31, 2010 10-Q 2011-09-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.